Effective first-line therapy for treatment of obesity Glucagon-like peptide-1 receptor agonists have emerged as a promising class of anti-obesity medications DATE: Nov 28, 2023 | CATEGORY: Wellness | AUTHOR: Joe Yammine, MD
